Reproductive outcomes of fertility sparing surgeries in germ cell tumours

Ujwala Prakash Wakpaijan

Abstract


The main aim of the study is to observe the reproductive outcome in patient of germ cell tumour after fertility preserving surgery. In which retrospective records of patients diagnosed with malignant GCT in young patients treated with fertility sparing surgery and chemotherapy for ten years from 2000 to 2009. From the careful observations concluded the overall survival with the patients treated with fertility sparing surgery is excellent and the reproductive outcome is more or less equivalent to the general population of same age group.


Keywords


Germ Cell Tumour; fertility; young patients

Full Text:

PDF

References


Lee PA, Migeon CJ. Puberty in boys: correlation of plasma levels of gonadotropins (LH, FSH), androgens (testosterone, androstenedione, dehydroepiandrosterone and its sulfate), estrogens (estrone and estradiol) and progestins (progesterone and 17-hydroxyprogesterone). J Clin Endocrinol Metab. 1975 Sep;41(3):556-62.

Kleine W. Results of fertility preserving operations in malignant ovarian tumors. Zentralbl Gynakol. 1996;118(6):317-21.

Yoo SC1, Kim WY, Yoon JH, Chang SJ, Chang KH, Ryu HS. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy. Acta Obstet Gynecol Scand. 2010;89(1):126-30. doi: 10.3109/00016340903348383.

Xi MR1, Hou MM, Cao ZY, Zhang CS, Peng ZL, Wang HJ, Zheng A. Evaluation of the effect of fertility-saving surgery on young patients with malignant ovarian tumors. Zhonghua Fu Chan Ke Za Zhi. 2006 Apr;41(4):233-6.

Turkmen O, Karalok A, Basaran D, Kimyon GC, Tasci T, Ureyen I, Tulunay G, Turan T. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors. J Adolesc Young Adult Oncol. 2017 Jan 13. doi: 10.1089/jayao.2016.0086.

Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol. 2005 May;97(2):489-96.

Alwazzan AB, Popowich S, Dean E, Robinson C, Lotocki R, Altman AD. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center. Int J Gynecol Cancer. 2015 Nov;25(9):1616-22. doi: 10.1097/IGC.0000000000000541.

Gershenson DM. Irinotecan in epithelial ovarian cancer. Oncology (Williston Park). 2002 May;16(5 Suppl 5):29-31.

Zanetta G, Bonazzi C, Cantù M, Binidagger S, Locatelli A, Bratina G, Mangioni C. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol. 2001 Feb 15;19(4):1015-20.

Wee JY, Li X, Chern BS, Chua IS. Struma ovarii: management and follow-up of a rare ovarian tumour. Singapore Med J. 2015 Jan; 56(1):35-9.




DOI: http://dx.doi.org/10.21746/ijbio.2017.02.007

Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.